[1] 谭垚. 2型糖尿病患者微血管病变与血糖波动的关系及其影响因素分析[D]. 延安: 延安大学, 2019.
[2] ANDERSSON E, PERSSON S, HALLÉN N, et al. Costs of diabetes complications: hospital-based care and absence from work for 392 200 people with type 2 diabetes and matched control participants in Sweden[J]. Diabetologia, 2020, 63(12): 2582. doi: 10.1007/s00125-020-05277-3
[3] BECK RW, CONNOR CG, MULLEN DM, et al. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading[J]. Diabetes Care, 2017, 40(8): 994. doi: 10.2337/dc17-0636
[4] 蔡璟浩, 周健. 《2021年美国糖尿病学会糖尿病医学诊疗标准》解读[J/CD]. 中国医学前沿杂志(电子版), 2021, 13(2): 13.
[5] 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292.
[6] 邝嘉敏, 顾炽昌, 梁勇前. 血糖控制目标范围内时间与糖尿病视网膜病变的相关性分析[J]. 广州医科大学学报, 2021, 49(4): 99.
[7] 唐青青, 郭英, 张广栋, 等. 葡萄糖目标范围内时间和糖化血红蛋白水平与糖尿病视网膜病变风险的相关性研究[J]. 中华眼底病杂志, 2022, 38(1): 20.
[8] 郗光霞, 安平, 梁登耀, 等. 糖化血红蛋白水平和血糖波动与氧化应激关系的研究[J]. 中国糖尿病杂志, 2021, 29(2): 99.
[9] CHATZIRALLI IP. The role of glycemic control and variability in diabetic retinopathy[J]. Diabetes Ther, 2018, 9(1): 431. doi: 10.1007/s13300-017-0345-5
[10] 白倩, 陈琰, 代闪, 等. 2型糖尿病患者血糖波动指标与MAU的相关性[J]. 临床与病理杂志, 2019, 39(8): 1698.
[11] 吕玲. 葡萄糖目标范围内时间与2型糖尿病肾脏疾病的相关性研究[D]. 长春: 吉林大学, 2021.
[12] AGIOSTRATIDOU G, ANHALT H, BALL D, et al. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF international, the Leona M. and Harry B. Helmsley Charitable Trust, the pediatric Endocrine Society, and the T1D exchange[J]. Diabetes care, 2017, 40(12): 1622. doi: 10.2337/dc17-1624
[13] BECK RW, BERGENSTAL RM, RIDDLESWORTH TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials[J]. Diabetes care, 2019, 42(3): 400.
[14] LU J, MA X, ZHOU J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes[J]. Diabetes Care, 2018, 41(11): 2370.
[15] 陆静毅, 戴冬君, 周健. 糖尿病管理新指标: 葡萄糖在目标范围内时间的研究现状及展望[J]. 中华医学杂志, 2020, 100(38): 2961.
[16] 中国2型糖尿病防治指南(2020年版)(上)[J]. 中国实用内科杂志, 2021, 41(8): 668.